liposomal bupivicaine

PreclinicalSmall molecule

UUnited States Naval Medical Center, San Diego

liposomal bupivicaine is one of 4 small molecule programs targeting General Surgery. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

General SurgeryCompleted

General SurgeryPreclinical

Completed

Competition

Competitive Landscape

3 competitors in General Surgery

#DrugCompanyPhaseTrials

Peridex

DDexcel Pharma Technologies Ltd.

Approved

1 2

Tylenol

KKenvue Brands

Approved

1 3

Advil

KKenvue Brands

Approved

1 4

liposomal bupivicaine

UUnited States Naval Medical Center, San Diego

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Liposomal Bupivacaine3 trials

A Study Comparing Fascia Iliaca Blockade vs Extracapsular Local Field Infiltration With Liposomal Bupivacaine

Completed·—·Phase 4·NCT04114058·37 enrolled

Efficacy of Liposomal Bupivacaine for Pain Control After Percutaneous Nephrostolithotomy

Withdrawn·NNorthwell Health·Phase 3·NCT03043027

Liposomal Bupivacaine in Ambulatory Hand Surgery

Withdrawn·LLoma Linda University·Phase 3·NCT02933814

Infiltration1 trial

Surgeon Infiltration QL Block Comparison

Completed·—·Phase 4·NCT03496610·44 enrolled

General Surgery1 trial

Trial of Liposomal Versus Plain Bupivacaine in Minimally Invasive General Surgery Procedures

Completed·UUnited States Naval Medical Center, San Diego·N/A·NCT02875288·100 enrolled

Rotator Cuff Surgery1 trial

Single Shot Liposomal Bupivicaine in Rotator Cuff Surgery

Completed·IIndiana University·Phase 4·NCT03822182·78 enrolled

Pain Management1 trial

Pain Management in Response to Exparel vs. Standard Bupivicaine

Completed·IInova Health Care Services·Phase 4·NCT02499159·100 enrolled

1 more indication

Rebound Pain1 trial

A Comparison of Liposomal Bupivacaine Versus Ropivacaine for Interscalene Brachial Plexus Block in Alleviating Rebound Pain Following Shoulder Arthroscopy

Completed·LLiu Jiuhong·Approved·NCT07196631·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for liposomal bupivicaine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — liposomal bupivicaine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for liposomal bupivicaine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — United States Naval Medical Center, San Diego company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUnited States Naval Medical Center, San Diego

liposomal bupivicaine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Liposomal Bupivacaine3 trials

Infiltration1 trial

General Surgery1 trial

Rotator Cuff Surgery1 trial

Pain Management1 trial

Rebound Pain1 trial

References

Drug Info

Quick Facts

Related News